Page last updated: 2024-08-17

levodopa and Sleep Wake Disorders

levodopa has been researched along with Sleep Wake Disorders in 93 studies

Research

Studies (93)

TimeframeStudies, this research(%)All Research%
pre-199013 (13.98)18.7374
1990's19 (20.43)18.2507
2000's31 (33.33)29.6817
2010's24 (25.81)24.3611
2020's6 (6.45)2.80

Authors

AuthorsStudies
Acera, M; Ayala, U; Carmona, M; Del Pino, R; Fernández, M; Fernández, T; Gabilondo, I; Gómez-Esteban, JC; Murueta-Goyena, A; Tijero, B1
Kovrov, GV; Nodel, MR; Shevtsova, KV1
Kaminska, M; Lafontaine, AL; Scanga, A1
Batzu, L; Falup-Pecurariu, C; Leta, V; Qamar, MA; Ray Chaudhuri, K; Tall, P1
Kataoka, H; Kurumatani, N; Obayashi, K; Saeki, K; Sugie, K1
Becker, S; Berg, D; Busch, JH; Elshehabi, M; Emmert, K; Hansen, C; Liepelt-Scarfone, I; Maetzler, W; Nussbaum, S; Roeben, B; Schaeffer, E; Synofzik, M; Vaterrodt, T; Zaunbrecher, L1
Fu, YT; Huang, JY; Li, J; Liu, CF; Liu, JY; Ma, LJ; Mao, CJ; Wang, Y; Zhang, HJ1
Angrisano, S; Cicolin, A; Lopiano, L; Merola, A; Montanaro, E; Priano, L; Romagnolo, A; Tribolo, A; Zibetti, M1
Antonini, A; Ashkan, K; Dafsari, HS; Dembek, TA; Evans, J; Mahlstedt, P; Martinez-Martin, P; Ray-Chaudhuri, K; Rizos, A; Sachse, L; Silverdale, M; Steffen, J; Strack, M; Timmermann, L; Visser-Vandewalle, V1
Amato, N; Galati, S; Kaelin-Lang, A; Manconi, M; Möller, JC; Sarasso, S; Staedler, C; Stanzione, P1
Cantor, C; Chahine, LM; Colcher, A; Dahodwala, N; Daley, J; Duda, JE; Horn, S; Hurtig, H1
Antczak, JM; Banach, M; Derejko, M; Jakubczyk, T; Jernajczyk, W; Rakowicz, MJ; Sienkiewicz, J; Więcławska, M; Zalewska, U1
An, J; Chan, P; Gu, Z; Wang, C; Zhang, H1
Cohen, AD; Liu, W; Ye, M; Zhang, N; Zhang, Y1
Bauer, L; Chung, SJ; Ikeda, J; Jeon, BS; Kim, JM; Kim, JW; Singh, P; Thierfelder, S1
Baybas, S; Dirican, A; Dogan, GB; Dogan, VB; Koksal, A1
Adrien, J; Belaid, H; François, C; Hirsch, EC; Karachi, C1
Bird, LM; Tan, WH1
Bove, F; Espay, AJ; Espay, KJ; Fasano, A; Krikorian, R; Lena, F; Modugno, N; Poon, YY; Ricciardi, L1
Bonkowsky, JL; Chen, YC; Panula, P; Rozov, S; Semenova, S; Sundvik, M1
Zeitlhofer, J1
Sethi, K1
Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D1
Burn, DJ; McKeith, IG; Minett, T; Molloy, S; O'Brien, JT1
Brandauer, E; El-Demerdash, E; Frauscher, B; Gschliesser, V; Högl, B; Kaneider, M; Poewe, W; Rücker, L1
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S1
Diederich, NJ; Fénelon, G; Goetz, CG; Stebbins, G1
Stacy, M1
Cardinali, DP; Merello, M; Perez-Lloret, S; Rossi, M; Santiago, PL1
Deuschl, G; Herzog, J; Volkmann, J; Wailke, S; Witt, K1
Brotchie, JM; Fox, SH1
Cronin-Golomb, A; Stavitsky, K1
Evers, S; Happe, S; Hornyak, M; Stiasny-Kolster, K1
Bloem, BR; Munneke, M; Petzinger, GM; Speelman, AD; van de Warrenburg, BP; van Nimwegen, M1
Fook-Chong, S; Lim, LL; Pavanni, R; Tan, EK; Yong, MH1
Schnitzler, A; Südmeyer, M; Wojtecki, L1
Li, M; Li, SD; Liu, Y; Yang, MH1
Bravo-Utrera, M; Burguera, JA; Campos-Arillo, VM; Chacón, JR; Durán-Herrera, C; Fernández-García, JM; García-Ramos, R; García-Ruiz, PJ; Gómez-Esteban, JC; Grandas, FJ; Gutierrez, J; Juni, J; Luquin, MR; Martí, MJ; Martínez-Castrillo, JC; Mata, M; Olivares, J; Ribacoba-Montero, R; Rojo, A; Santos-García, D; Sierra, M; Valero-Merino, C; Vela, L1
Mrowka, M; Odin, P; Shing, M1
Ongini, E1
Abdelgabar, A; Sharma, J1
De Mello, MT; Esteves, AM; Tufik, S1
Oertel, WH; Stiasny-Kolster, K1
Benbir, G; Kaynak, D; Kaynak, H; Kiziltan, G; Uysal, O1
Comella, CL; Janko, K; Morrissey, M1
Ludin, HP1
Schapira, AH1
Jansson, R; Nyholm, D; Remahl, IN; Willows, T1
Le Rhun, E; Lebert, F1
Bilbao, I; Ciordia, R; Gómez-Esteban, JC; Lezcano, E; Losada, J; Rouco, I; Velasco, F; Zarranz, JJ1
Diamond, A; Jankovic, J1
Borek, LL; Friedman, JH; Kohn, R1
Happe, S; Lanz, M1
Fertl, E1
Chan, DK; Cordato, DJ; O'Rourke, F1
Yung, CY1
Baum, R; Glantz, R; Klawans, HL; Nausieda, PA; Weber, S1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N1
Chkili, T; el Alaoui-Faris, M; Nadifi, M; Ouahabi, H1
Allen, RP; Buchholz, DW; Kaplan, PW; Walters, JK1
Iivanainen, M; Kaakkola, S1
De Deyn, PP; Gonce, M; Jacquy, J; Van den Kerchove, M1
Kazenwadel, J; Kohnen, R; Krüger, HP; Künzel, M; Pollmächer, T; Ramm, S; Schwarz, J; Stiasny, K; Trenkwalder, C; Wetter, T1
Emrich, D; Hajak, G; Kögler, A; Munz, DL; Riemann, H; Rüther, E; Staedt, J; Stoppe, G1
Kazenwadel, J; Kohnen, R; Künzel, M; Oertel, WH; Pollmächer, T; Stiasny, K; Trenkwalder, C; Wetter, TC1
Fahn, S; Salgado, M; Tan, A1
Dowling, GA1
Lavigne, GJ; Lobbezoo, F; Montplaisir, JY; Tanguay, R1
Marsden, CD; Nordera, G; Stocchi, F1
Nozawa, T1
Barbato, L; Berardelli, A; Nordera, G; Ruggieri, S; Stocchi, F1
Amoiridis, G; Haan, J; Przuntek, H; Riess, O; Schöls, L1
Jönsson, R; Lindberg, E; Mallon, L; Nyström, B; Ulfberg, J1
Abele, M; Dichgans, J; Klockgether, T; Leonhardt, M; Weller, M1
Ellis, CM; Ray Chaudhuri, K; Reuter, I1
Karlsen, K; Larsen, JP; Tandberg, E1
Castro-Caldas, A; Ferreira, JJ; Montastruc, JL; Rascol, O; Thalamas, C1
Bergamasco, B; Lanotte, M; Lopiano, L; Melcarne, A; Perozzo, P; Rizzone, M; Tavella, A; Torre, A1
Díaz, V; Miranda, M; Venegas, P; Villagra, R1
Bailbé, M; Dumas, P; Gil, R; Karolewicz, S; Neau, JP1
Balestre, E; Bioulac, B; Chrysostome, V; Ghorayeb, I; Tison, F; Yekhlef, F1
Clark, RW; Malarkey, WB; Schmidt, HS1
Lapierre, O; Montplaisir, J; Pelletier, G; Warnes, H1
Pfeiffer, R1
Costeff, H; Gadoth, N; Harel, S; Lavie, P1
Boivin, DB; Montplaisir, J; Poirier, G1
Bédard, MA; Godbout, R; Montplaisir, J; Poirier, G1
Klawans, HL1
Sandyk, R1
Askenasy, JJ; Yahr, MD1
AuAutret, A1
Baker, AB; Loewenson, RB; Martin, WE; Resch, JA1
Fischer, PA; Jacobi, P; Maxion, H; Schneider, E1

Reviews

28 review(s) available for levodopa and Sleep Wake Disorders

ArticleYear
An overview of the effects of levodopa and dopaminergic agonists on sleep disorders in Parkinson's disease.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023, 06-01, Volume: 19, Issue:6

    Topics: Dopamine Agonists; Humans; Levodopa; Neurodegenerative Diseases; Parkinson Disease; Quality of Life; Sleep Wake Disorders

2023
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2023, Volume: 130, Issue:11

    Topics: Antiparkinson Agents; Dopamine; Humans; Levodopa; Parkinson Disease; Sleep; Sleep Wake Disorders

2023
Pharmacological therapies for Angelman syndrome.
    Wiener medizinische Wochenschrift (1946), 2017, Volume: 167, Issue:9-10

    Topics: Angelman Syndrome; Animals; Clinical Trials as Topic; Disease Models, Animal; Gene Silencing; Levodopa; Mice; Minocycline; Oligoribonucleotides, Antisense; Seizures; Sleep Wake Disorders; Topoisomerase Inhibitors; Ubiquitin-Protein Ligases

2017
Levodopa unresponsive symptoms in Parkinson disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23 Suppl 3

    Topics: Antiparkinson Agents; Anxiety; Depression; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Sweating; Xerostomia

2008
Treatment of early Parkinson's disease. Part 2.
    European neurology, 2009, Volume: 61, Issue:4

    Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors

2009
Hallucinations in Parkinson disease.
    Nature reviews. Neurology, 2009, Volume: 5, Issue:6

    Topics: Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Hallucinations; Humans; Illusions; Levodopa; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Sleep Wake Disorders

2009
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
    Progress in brain research, 2010, Volume: 184

    Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Basal Ganglia; Cognition Disorders; Disease Models, Animal; Dopamine; Drug Discovery; Endpoint Determination; Humans; Levodopa; Movement; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Primates; Psychoses, Substance-Induced; Sleep Wake Disorders

2010
[Restless legs syndrome and nocturnal leg pain : Differential diagnosis and treatment].
    Schmerz (Berlin, Germany), 2011, Volume: 25, Issue:5

    Topics: Anticonvulsants; Circadian Rhythm; Comorbidity; Cross-Sectional Studies; Diagnosis, Differential; Dopamine Agonists; Humans; Leg; Levodopa; Pain; Restless Legs Syndrome; Risk Factors; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders

2011
How might physical activity benefit patients with Parkinson disease?
    Nature reviews. Neurology, 2011, Jul-12, Volume: 7, Issue:9

    Topics: Antiparkinson Agents; Cardiovascular Diseases; Cognition; Constipation; Depressive Disorder; Dopamine; Humans; Levodopa; Motor Activity; Muscle Fatigue; Osteoporosis; Parkinson Disease; Psychomotor Performance; Quality of Life; Sedentary Behavior; Sleep Wake Disorders

2011
[Current treatment strategies for Parkinson's disease].
    Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:12

    Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor

2011
[Levodopa in the treatment of Parkinson's disease: myths and realties].
    Revista de neurologia, 2012, Dec-01, Volume: 55, Issue:11

    Topics: Antiparkinson Agents; Humans; Levodopa; Mental Disorders; Motor Activity; Parkinson Disease; Quality of Life; Sleep Wake Disorders

2012
Restless legs syndrome.
    European journal of neurology, 2002, Volume: 9 Suppl 3

    Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Child; Diagnosis, Differential; Dopamine Agonists; Humans; Levodopa; Narcotics; Nervous System Diseases; Neurologic Examination; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders

2002
Sleep disorders in Parkinson's disease.
    International journal of clinical practice, 2003, Volume: 57, Issue:9

    Topics: Antiparkinson Agents; Humans; Levodopa; Pain; Parkinson Disease; Quality of Life; Sleep; Sleep Wake Disorders

2003
[Idiopathic Parkinson's disease: practical hints for the treatment].
    Praxis, 2005, Jul-27, Volume: 94, Issue:30-31

    Topics: Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Benserazide; Cholinesterase Inhibitors; Clozapine; Dementia; Depression; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease; Quality of Life; Sleep Wake Disorders; Time Factors

2005
Present and future drug treatment for Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:11

    Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence

2005
[Treatment of dementia with Lewy bodies].
    Revue neurologique, 2006, Volume: 162, Issue:1

    Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy

2006
Treatment of advanced Parkinson's disease.
    Expert review of neurotherapeutics, 2006, Volume: 6, Issue:8

    Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition Disorders; Humans; Levodopa; Mental Disorders; Parkinson Disease; Sleep Wake Disorders

2006
[When the legs have to keep moving at night--the restless legs syndrome].
    MMW Fortschritte der Medizin, 2007, May-21, Volume: 149 Suppl 2

    Topics: Adult; Amines; Analgesics, Opioid; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Dopamine Agonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Polysomnography; Pregnancy; Quality of Life; Restless Legs Syndrome; Sleep Wake Disorders; Time Factors

2007
Management for motor and non-motor complications in late Parkinson's disease.
    Geriatrics, 2008, Volume: 63, Issue:5

    Topics: Accidental Falls; Aged; Antiparkinson Agents; Comorbidity; Dementia; Dyskinesias; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Sleep Wake Disorders

2008
A review of clinical trials of lithium in neurology.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 21 Suppl 1

    Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis

1984
[L-dopa-responsive dystonia: 2 familial cases of adult onset with sleep disorders].
    Revue neurologique, 1995, Volume: 151, Issue:5

    Topics: Adult; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Sleep Wake Disorders

1995
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:2

    Topics: Antiparkinson Agents; Apomorphine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Globus Pallidus; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Sleep Wake Disorders; Stereotaxic Techniques; Thalamus

1997
[Periodic limb movement disorder].
    Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:2

    Topics: Anticonvulsants; Clonazepam; Diagnosis, Differential; Dopamine Agents; Humans; Levodopa; Movement Disorders; Periodicity; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders

1998
Sleep disorders in Parkinson's disease.
    Journal of neurology, 1998, Volume: 245 Suppl 1

    Topics: Aged; Aged, 80 and over; Aging; Antiparkinson Agents; Clinical Trials as Topic; Humans; Levodopa; Middle Aged; Motor Activity; Muscle, Skeletal; Parkinson Disease; Respiration; Sleep Wake Disorders

1998
[Restless legs. A much neglected syndrome].
    Lakartidningen, 1999, Mar-10, Volume: 96, Issue:10

    Topics: Adolescent; Adult; Anticonvulsants; Clonazepam; Dopamine Agents; Humans; Levodopa; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders; Terminology as Topic

1999
The treatment of the restless leg syndrome with or without periodic leg movements in sleep.
    Sleep, 1992, Volume: 15, Issue:5

    Topics: Anti-Anxiety Agents; Clonazepam; Dextropropoxyphene; Dopamine Agents; Humans; Levodopa; Narcotics; Polysomnography; Restless Legs Syndrome; Sleep Stages; Sleep Wake Disorders

1992
Optimization of levodopa therapy.
    Neurology, 1992, Volume: 42, Issue:1 Suppl 1

    Topics: Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Sleep Wake Disorders

1992
Psychiatric side effects during the treatment of Parkinson's disease.
    Journal of neural transmission. Supplementum, 1988, Volume: 27

    Topics: Dreams; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa; Mental Disorders; Paranoid Disorders; Parkinson Disease; Serotonin; Severity of Illness Index; Sleep Wake Disorders

1988

Trials

22 trial(s) available for levodopa and Sleep Wake Disorders

ArticleYear
The heterogeneity of non-motor symptoms of Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Asian People; Digestive System Abnormalities; Female; Humans; Levodopa; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Mood Disorders; Parkinson Disease; Retrospective Studies; Sensation Disorders; Severity of Illness Index; Sleep Wake Disorders; Young Adult

2015
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
    BMC neurology, 2015, Feb-28, Volume: 15

    Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes

2015
Levodopa use and sleep in patients with dementia with Lewy bodies.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Mar-15, Volume: 24, Issue:4

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Lewy Body Disease; Male; Mental Status Schedule; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires; Time Factors

2009
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult

2009
Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease.
    European journal of neurology, 2011, Volume: 18, Issue:4

    Topics: Aged; Aged, 80 and over; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Sleep; Sleep Wake Disorders

2011
[Effects of bushenhuoxue granules on sleep quality in Parkinson's patients].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2011, Volume: 34, Issue:9

    Topics: Aged; Aged, 80 and over; Benserazide; Double-Blind Method; Drug Combinations; Drugs, Chinese Herbal; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phytotherapy; Plants, Medicinal; Polysomnography; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome

2011
Comparison between dopaminergic agents and physical exercise as treatment for periodic limb movements in patients with spinal cord injury.
    Spinal cord, 2004, Volume: 42, Issue:4

    Topics: Adult; Dopamine Agents; Drug Administration Schedule; Exercise; Extremities; Female; Follow-Up Studies; Humans; Injury Severity Score; Levodopa; Male; Middle Aged; Movement; Polysomnography; Probability; Prospective Studies; Risk Assessment; Sleep Wake Disorders; Spinal Cord Injuries; Treatment Outcome

2004
Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
    Neuropsychobiology, 2004, Volume: 50, Issue:1

    Topics: Administration, Oral; Aged; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Pramipexole; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Thiazoles; Treatment Outcome

2004
Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
    European journal of neurology, 2005, Volume: 12, Issue:3

    Topics: Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Polysomnography; Prospective Studies; Sleep Stages; Sleep Wake Disorders

2005
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
    Neurology, 2005, Apr-26, Volume: 64, Issue:8

    Topics: Age Factors; Aged; Antiparkinson Agents; Brain; Circadian Rhythm; Constipation; Dizziness; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Placebos; Sex Factors; Sleep; Sleep Wake Disorders; Treatment Outcome

2005
A review of clinical trials of lithium in neurology.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 21 Suppl 1

    Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis

1984
Pergolide in late-stage Parkinson disease.
    Annals of neurology, 1982, Volume: 12, Issue:3

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders

1982
A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.
    Sleep, 1993, Volume: 16, Issue:8

    Topics: Adult; Aged; Carbidopa; Dextropropoxyphene; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement; Polysomnography; Reaction Time; Restless Legs Syndrome; Sleep Wake Disorders; Time Factors

1993
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
    Sleep, 1995, Volume: 18, Issue:8

    Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Quality of Life; Restless Legs Syndrome; Sleep Wake Disorders; Uremia

1995
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
    Journal of neural transmission. General section, 1995, Volume: 99, Issue:1-3

    Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon

1995
[Treatment of idiopathic and uremic restless legs syndrome with L-dopa--a double-blind cross-over study].
    Wiener medizinische Wochenschrift (1946), 1995, Volume: 145, Issue:17-18

    Topics: Administration, Oral; Adult; Aged; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Quality of Life; Restless Legs Syndrome; Sleep Wake Disorders; Uremia

1995
The effect of catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:1

    Topics: Adult; Benserazide; Bruxism; Cross-Over Studies; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Electromyography; Female; Humans; Levodopa; Male; Polysomnography; Sleep Wake Disorders

1997
Sleep disorders in Parkinson's disease.
    Journal of neurology, 1998, Volume: 245 Suppl 1

    Topics: Aged; Aged, 80 and over; Aging; Antiparkinson Agents; Clinical Trials as Topic; Humans; Levodopa; Middle Aged; Motor Activity; Muscle, Skeletal; Parkinson Disease; Respiration; Sleep Wake Disorders

1998
Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
    Acta neurologica Scandinavica, 1999, Volume: 100, Issue:3

    Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Drug Administration Schedule; Follow-Up Studies; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease; Restless Legs Syndrome; Sleep Wake Disorders

1999
The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy.
    Clinical neuropharmacology, 1989, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Double-Blind Method; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Sleep; Sleep Wake Disorders; Sleep, REM

1989
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Neurology, 1974, Volume: 24, Issue:10

    Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Placebos; Sleep Wake Disorders; Time Factors; Trihexyphenidyl; Vomiting

1974
Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.
    European neurology, 1974, Volume: 12, Issue:5-6

    Topics: Aged; Amides; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior; Clinical Trials as Topic; Depression; Dopa Decarboxylase; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levodopa; Male; Melanocyte-Stimulating Hormones; Middle Aged; Oligopeptides; Parkinson Disease; Pituitary Hormone-Releasing Hormones; Placebos; Psychomotor Disorders; Sleep Wake Disorders

1974

Other Studies

45 other study(ies) available for levodopa and Sleep Wake Disorders

ArticleYear
Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease.
    PloS one, 2021, Volume: 16, Issue:12

    Topics: Age Factors; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Photoperiod; Sex Factors; Sleep Wake Disorders

2021
[The factors impact on the urgent daytime sleepiness degree in the Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:10

    Topics: Aged; Disorders of Excessive Somnolence; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Sleep Wake Disorders; Sleepiness

2022
Objective sleep measures between patients with Parkinson's disease and community-based older adults.
    Sleep medicine, 2020, Volume: 68

    Topics: Aged; Cross-Sectional Studies; Humans; Levodopa; Parkinson Disease; Polysomnography; Sleep; Sleep Wake Disorders

2020
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.
    Journal of neurology, 2021, Volume: 268, Issue:7

    Topics: Antiparkinson Agents; Humans; Levodopa; Movement; Parkinson Disease; Sleep; Sleep Wake Disorders

2021
Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients.
    Pain practice : the official journal of World Institute of Pain, 2018, Volume: 18, Issue:1

    Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Depression; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Musculoskeletal Pain; Pain; Pain Measurement; Parkinson Disease; Polysomnography; Quality of Life; Sleep; Sleep Wake Disorders; Sleep, REM

2018
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion.
    Journal of neurology, 2017, Volume: 264, Issue:6

    Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinsonian Disorders; Polysomnography; Severity of Illness Index; Sleep Wake Disorders; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome

2017
Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:3

    Topics: Aged; Antiparkinson Agents; Cardiovascular Abnormalities; Deep Brain Stimulation; Female; Humans; International Cooperation; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Quality of Life; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Subthalamic Nucleus; Surveys and Questionnaires; Treatment Outcome

2018
Levodopa-induced dyskinesia in Parkinson disease: Sleep matters.
    Annals of neurology, 2018, Volume: 84, Issue:6

    Topics: Actigraphy; Adult; Aged; Antiparkinson Agents; Depression; Dyskinesia, Drug-Induced; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Psychiatric Status Rating Scales; Sleep Wake Disorders; Statistics, Nonparametric

2018
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.
    Parkinsonism & related disorders, 2013, Volume: 19, Issue:10

    Topics: Age of Onset; Aged; Antiparkinson Agents; Cross-Sectional Studies; Dopamine Agents; Female; Humans; Hypnotics and Sedatives; Levodopa; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Polysomnography; Sleep; Sleep Stages; Sleep Wake Disorders; Sleep, REM

2013
Negative influence of L-dopa on subjectively assessed sleep but not on nocturnal polysomnography in Parkinson's disease.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:3

    Topics: Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Severity of Illness Index; Sleep; Sleep Wake Disorders; Surveys and Questionnaires

2013
Non-motor symptoms in treated and untreated Chinese patients with early Parkinson's disease.
    The Tohoku journal of experimental medicine, 2014, Volume: 232, Issue:2

    Topics: Age Factors; Antiparkinson Agents; China; Cohort Studies; Constipation; Depression; Dopamine Agonists; Humans; Levodopa; Logistic Models; Parkinson Disease; Sex Factors; Sleep Wake Disorders; Time Factors

2014
Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Depression; Depressive Disorder; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires

2015
Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.
    Sleep medicine, 2015, Volume: 16, Issue:10

    Topics: Animals; Antiparkinson Agents; Central Nervous System Depressants; Disease Models, Animal; Levodopa; Macaca fascicularis; Male; Melatonin; Parkinson Disease; Sleep Wake Disorders

2015
24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:4

    Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Muscle Rigidity; Outcome Assessment, Health Care; Parkinson Disease; Sleep Wake Disorders

2016
A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.
    The Journal of biological chemistry, 2016, Oct-14, Volume: 291, Issue:42

    Topics: Animals; Dopaminergic Neurons; Histamine; Hypothalamus; Levodopa; Neurotransmitter Agents; Orexins; Parkinson Disease; Serotonergic Neurons; Sleep Wake Disorders; Synaptic Transmission; Tyrosine 3-Monooxygenase; Zebrafish; Zebrafish Proteins

2016
[Treatment of the restless legs syndrome].
    MMW Fortschritte der Medizin, 2008, May-19, Volume: 150 Suppl 2

    Topics: Anticonvulsants; Diagnosis, Differential; Dopamine Agonists; Family Practice; Humans; Levodopa; Narcotics; Paresthesia; Polysomnography; Psychomotor Agitation; Restless Legs Syndrome; Sleep Wake Disorders

2008
The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
    Sleep medicine, 2009, Volume: 10, Issue:6

    Topics: Aged; Biomarkers; Cohort Studies; Disease Progression; Dopamine Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Ferritins; Humans; Levodopa; Male; Middle Aged; Prospective Studies; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders

2009
Medical treatment of Parkinson disease.
    Neurologic clinics, 2009, Volume: 27, Issue:3

    Topics: Amantadine; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Cognition Disorders; Corpus Striatum; Digestive System Physiological Phenomena; Dopamine Agonists; Enzyme Inhibitors; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Motor Activity; Movement Disorders; Neurons; Parkinson Disease; Sleep Wake Disorders; Substantia Nigra

2009
Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy.
    The International journal of neuroscience, 2010, Volume: 120, Issue:1

    Topics: Actigraphy; Activities of Daily Living; Aged; Case-Control Studies; Circadian Rhythm; Dopamine Agents; Female; Humans; Levodopa; Male; Pain Measurement; Parkinson Disease; Polysomnography; Predictive Value of Tests; Psychiatric Status Rating Scales; Sleep Wake Disorders; Statistics, Nonparametric; Wakefulness

2010
Sleep quality in Parkinson disease: an examination of clinical variables.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2011, Volume: 24, Issue:2

    Topics: Actigraphy; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sleep; Sleep Wake Disorders; Surveys and Questionnaires

2011
Case control polysomnographic studies of sleep disorders in Parkinson's disease.
    PloS one, 2011, Volume: 6, Issue:7

    Topics: Aged; Case-Control Studies; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Polysomnography; REM Sleep Behavior Disorder; Respiration; Restless Legs Syndrome; Sex Characteristics; Sleep Wake Disorders; Surveys and Questionnaires

2011
Adenosine A(2A) receptors in nonlocomotor features of Parkinson's disease: introduction.
    Neurology, 2003, Dec-09, Volume: 61, Issue:11 Suppl 6

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Central Nervous System; Depression; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Receptor, Adenosine A2A; Sleep Wake Disorders

2003
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Neurology, 2005, Nov-08, Volume: 65, Issue:9

    Topics: Akinetic Mutism; Antiparkinson Agents; Chronobiology Disorders; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Duodenum; Humans; Infusion Pumps; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Sleep Wake Disorders; Time; Time Factors; Treatment Outcome

2005
Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:7

    Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Sickness Impact Profile; Sleep Wake Disorders; Statistics as Topic

2006
Phenomenology of dreams in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2

    Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dreams; Female; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Semantics; Severity of Illness Index; Sleep Wake Disorders; Sleep, REM

2007
Comment to the paper of Medeiros CAM, et al. (2007) J Neurol 254:459-464.
    Journal of neurology, 2008, Volume: 255, Issue:5

    Topics: Antiparkinson Agents; Central Nervous System Depressants; Circadian Rhythm; Drug Administration Schedule; Drug Interactions; Humans; Levodopa; Melatonin; Parkinson Disease; Placebo Effect; Randomized Controlled Trials as Topic; Sleep; Sleep Wake Disorders; Time Factors

2008
Psychiatric complications of levodopa therapy of Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Circadian Rhythm; Hallucinations; Humans; Hydrocortisone; Levodopa; Mental Disorders; Mood Disorders; Parkinson Disease; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Thinking

1984
Dopa-responsive dystonia of childhood.
    Developmental medicine and child neurology, 1993, Volume: 35, Issue:4

    Topics: Adolescent; Biopterins; Child; Child, Preschool; Diagnosis, Differential; Dystonia; Electromyography; Female; Gait; Humans; Infant; Levodopa; Male; Muscle Tonus; Polysomnography; Posture; Sex Factors; Sleep Wake Disorders; Synaptic Transmission

1993
Sustained-release levodopa in parkinsonian patients with nocturnal disabilities.
    Acta neurologica Belgica, 1993, Volume: 93, Issue:1

    Topics: Aged; Aged, 80 and over; Delayed-Action Preparations; Humans; Levodopa; Longitudinal Studies; Middle Aged; Movement Disorders; Parkinson Disease; Sleep Wake Disorders

1993
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:2

    Topics: Aged; Antiparkinson Agents; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Sleep Wake Disorders; Sleep, REM

1996
Sleep in older women with Parkinson's disease.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1995, Volume: 27, Issue:6

    Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Circadian Rhythm; Cross-Sectional Studies; Female; Humans; Levodopa; Middle Aged; Nursing Assessment; Parkinson Disease; Sleep Stages; Sleep Wake Disorders; Wakefulness

1995
Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?
    Neurology, 1998, Volume: 51, Issue:6

    Topics: Adult; Aged; Dopamine Agents; Electrophysiology; Female; Genes, Dominant; Humans; Levodopa; Machado-Joseph Disease; Male; Middle Aged; Mutation; Polysomnography; Restless Legs Syndrome; Sleep Wake Disorders

1998
Pathological yawning (chasm) associated with periodic leg movements in sleep: cure by levodopa.
    Journal of neurology, 1999, Volume: 246, Issue:7

    Topics: Adult; Compulsive Behavior; Dopamine Agents; Fatigue; Female; Humans; Levodopa; Restless Legs Syndrome; Sleep Wake Disorders; Yawning

1999
Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5

    Topics: Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Dementia; Depression; Diabetes Mellitus; Drug Tolerance; Fatigue; Female; Humans; Levodopa; Male; Movement Disorders; Neurologic Examination; Norway; Outpatients; Parkinson Disease; Prevalence; Psychomotor Performance; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires

2000
Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients.
    Journal of neurology, 2001, Volume: 248, Issue:5

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sleep Wake Disorders

2001
Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease.
    European neurology, 2001, Volume: 46, Issue:1

    Topics: Aged; Antiparkinson Agents; Electric Stimulation Therapy; Humans; Levodopa; Male; Parkinson Disease; Sleep Wake Disorders; Subthalamic Nucleus

2001
[Sleepiness attacks while driving: adverse effects of new antiparkinson drugs].
    Revista medica de Chile, 2001, Volume: 129, Issue:5

    Topics: Antiparkinson Agents; Automobile Driving; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Sleep Wake Disorders

2001
[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
    Revue neurologique, 2002, Volume: 158, Issue:2

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Delusions; Female; France; Hallucinations; Health Surveys; Humans; Inpatients; Levodopa; Male; Middle Aged; Outpatients; Paranoid Disorders; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders

2002
Sleep disorders and their determinants in multiple system atrophy.
    Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 72, Issue:6

    Topics: Aged; Antiparkinson Agents; Depression; Female; Humans; Incidence; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders

2002
Disordered growth hormone and prolactin secretion in primary disorders of sleep.
    Neurology, 1979, Volume: 29, Issue:6

    Topics: Adult; Apnea; Arginine; Arousal; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Prolactin; Sleep Stages; Sleep Wake Disorders

1979
Motor abnormalities during sleep in patients with childhood hereditary progressive dystonia, and their unaffected family members.
    Sleep, 1989, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Basal Ganglia; Carbidopa; Child; Child, Preschool; Drug Combinations; Dystonia; Female; Genetic Carrier Screening; Humans; Levodopa; Male; Middle Aged; Motor Activity; Sleep Stages; Sleep Wake Disorders; Sleep, REM

1989
Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:5

    Topics: Adult; Central Nervous System; Dopamine; Female; Humans; Levodopa; Male; Movement Disorders; Restless Legs Syndrome; Sleep Wake Disorders; Sodium Oxybate; Synaptic Transmission

1986
Serotonergic mechanisms in levodopa-induced "on-off" and sleep disorders in Parkinson's disease.
    The International journal of neuroscience, 1988, Volume: 43, Issue:3-4

    Topics: Amitriptyline; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Serotonin; Sleep Wake Disorders

1988
Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study.
    Neurology, 1985, Volume: 35, Issue:4

    Topics: Aged; Carbidopa; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Receptors, Dopamine; Sleep Wake Disorders; Sleep, REM

1985
[Sleep: recent physiological acquisitions and clinical and pharmacological perspectives].
    La Revue du praticien, 1974, Nov-11, Volume: 24, Issue:51

    Topics: Animals; Brain; Cerebral Cortex; Electrocardiography; Electroencephalography; Electromyography; Electrooculography; Environment; Forecasting; Humans; Levodopa; Mental Disorders; Mesencephalon; Neurotransmitter Agents; Norepinephrine; Rats; Respiration; Reticular Formation; Sleep; Sleep Deprivation; Sleep Wake Disorders; Sleep, REM; Substance-Related Disorders; Telencephalon

1974